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Abstract. 
 
Calreticulin (CRT) and calnexin (CLNX) are 
lectin chaperones that participate in protein folding in 
the endoplasmic reticulum (ER). CRT is a soluble ER 
lumenal protein, whereas CLNX is a transmembrane 
protein with a cytosolic domain that contains two con-
sensus motifs for protein kinase (PK) C/proline-
directed kinase (PDK) phosphorylation. Using confo-
 
cal Ca
 
2
 
1
 
 imaging in 
 
Xenopus
 
 oocytes, we report here 
that coexpression of CLNX with sarco endoplasmic 
reticulum calcium ATPase (SERCA) 2b results in inhi-
bition of intracellular Ca
 
2
 
1
 
 oscillations, suggesting a 
functional inhibition of the pump. By site-directed mu-
tagenesis, we demonstrate that this interaction is regu-
lated by a COOH-terminal serine residue (S562) in 
CLNX. Furthermore, inositol 1,4,5-trisphosphate–
mediated Ca
 
2
 
1
 
 release results in a dephosphorylation 
of this residue. We also demonstrate by coimmunopre-
cipitation that CLNX physically interacts with the 
COOH terminus of SERCA2b and that after dephos-
phorylation treatment, this interaction is significantly 
reduced. Together, our results suggest that CRT is 
uniquely regulated by ER lumenal conditions, whereas 
CLNX is, in addition, regulated by the phosphorylation 
status of its cytosolic domain. The S562 residue in 
CLNX acts as a molecular switch that regulates the
interaction of the chaperone with SERCA2b, thereby 
affecting Ca
 
2
 
1
 
 signaling and controlling Ca
 
2
 
1
 
-sensitive 
chaperone functions in the ER.
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Introduction
 
Multiple cellular processes, including the control of gene
transcription (Dolmetsch et al., 1998; Li et al., 1998), growth
cone formation in neurons (Gomez and Spitzer, 1999), and
activation of mitochondrial respiration (Robb-Gaspers et
al., 1998) are encoded by spatial–temporal aspects of intra-
cellular Ca
 
2
 
1
 
 oscillations. Repetitive cytosolic Ca
 
2
 
1
 
 tran-
sients in 
 
Xenopus
 
 oocytes are under the control of two ma-
jor opposing factors: Ca
 
2
 
1
 
 release through the inositol
1,4,5-trisphosphate
 
 
 
receptor channel (IP
 
3
 
R)
 
1
 
 (Iino, 1990;
Parker and Ivorra, 1990; Bezprozvanny et al., 1991; Finch
et al., 1991) and Ca
 
2
 
1
 
 reuptake into the ER Ca
 
2
 
1
 
 store by
 
the Ca
 
2
 
1
 
 ATPases (Camacho and Lechleiter, 1993; MacLen-
nan et al., 1997). Sarco endoplasmic reticulum calcium
ATPase (SERCA)-type ATPases control the frequency of
IP
 
3
 
-induced Ca
 
2
 
1
 
 oscillations in 
 
Xenopus
 
 oocytes (Ca-
macho and Lechleiter, 1993). We have demonstrated pre-
viously that calreticulin (CRT), a lectin chaperone located
in the ER, inhibits these oscillations and specifically tar-
gets SERCA2b (Camacho and Lechleiter, 1995a; John et
al., 1998). The COOH terminus of SERCA2b, unlike that
of SERCA2a, faces the ER lumen and contains an as-
paragine residue that forms part of a consensus site for
N-linked glycosylation (N1036) (Gunteski-Hamblin et al.,
1988) that we demonstrated is required for interaction
with CRT (John et al., 1998). From these data we con-
cluded that a functional interaction between CRT and
SERCA2b may be required for inhibition of these oscilla-
tions.
CRT is a soluble lumenal ER protein, whereas calnexin
(CLNX) and its testis-specific isoform, calmegin (CLMG),
are type I transmembrane (TM) proteins (Michalak et al.,
1992; Bergeron et al., 1994; Ohsako et al., 1994; Watanabe
et al., 1994). This family of molecular chaperones is char-
acterized by a lumenal domain that contains a motif of 17
amino acids repeated three times in CRT and four in
CLNX and CLMG (Fliegel et al., 1989; Michalak et al.,
1992; Ohsako et al., 1994; Watanabe et al., 1994). This do-
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main is responsible for interaction of the chaperone with
the monoglucosylated form of N-linked glycoproteins dur-
ing protein folding in the ER (Vassilakos et al., 1998). The
presence of this conserved domain led us to test whether
CLNX, like CRT, also inhibits Ca
 
2
 
1
 
 oscillations. Here, we
demonstrate that CLNX inhibits Ca
 
2
 
1
 
 oscillations in a man-
ner consistent with inhibition of SERCA2b. Furthermore,
as was the case for CRT, repetitive Ca
 
2
 
1
 
 waves were unaf-
fected by coexpression of CLNX with a SERCA2b mutant
lacking the lumenal asparagine (SERCA2b-N1036A).
In contrast to CRT, CLNX has in its cytosolic domain
consensus sites for phosphorylation by protein kinase
(PK) C, casein kinase II, PKA, and proline-directed kinase
(PDK) (Tjoelker et al., 1994; Wong et al., 1998). Recently,
serine 562 located close to the COOH terminus of CLNX
has been shown to support phosphorylation by the PDK,
extracellular-signal regulated kinase 1 (ERK-1) (Wong et
al., 1998), and was implicated in regulating an interaction
of CLNX with ribosomal proteins (Chevet et al., 1999).
The second residue, S485, faces the cytosol in proximity to
the single TM segment. However, phosphorylation of this
residue has eluded detection (Wong et al., 1998). Since ac-
tivation of the IP
 
3
 
 signaling pathway results in the produc-
tion of both IP
 
3
 
 and diacylglycerol (DAG), which is a
known activator of PKC, we have also tested whether the
two consensus motifs for PKC/PDK phosphorylation in
CLNX play a role in the modulation of Ca
 
2
 
1
 
 oscillations.
Here we demonstrate that when the S562 is mutated to an
unreactive alanine (S562A), Ca
 
2
 
1
 
 oscillations are no longer
inhibited, suggesting that S562 in CLNX plays a critical
role in the regulation of Ca
 
2
 
1
 
 oscillations. The presence of
the S485 was required for regulation by S562. By immuno-
precipitation of CLNX from 
 
32
 
P-labeled oocytes, we dem-
onstrate that CLNX becomes de-phosphorylated in S562
after mobilization of intracellular Ca
 
2
 
1
 
 by IP
 
3
 
. Further-
more, we demonstrate by coimmunoprecipitation that
CLNX physically interacts with the COOH terminus of
SERCA2b and that this interaction is reduced when aspar-
agine 1036 is mutated to alanine. In addition, the inter-
action of CLNX with the COOH terminus of SERCA2b
is significantly reduced by dephosphorylation treatment.
Thus, we have identified a phosphorylated residue in
CLNX that is dephosphorylated in a Ca
 
2
 
1
 
-sensitive man-
ner, regulating SERCA2b to control ER store refilling and
as a consequence, to maintain the integrity of the Ca
 
2
 
1
 
-
sensitive protein folding machinery.
 
Materials and Methods
 
Construction of Expression Vectors
 
All cDNAs used in this study were subcloned between the 5
 
9
 
 and 3
 
9
 
 un-
translated regions of 
 
Xenopus
 
 
 
laevis
 
 
 
b
 
-globin into a vector (pHN) as de-
scribed previously (Camacho and Lechleiter, 1995a,b). The cDNA encoding
rat CLNX (Tjoelker et al., 1994) was excised from the pRc/CMV vector
by BamHI and XbaI (restriction enzymes from GIBCO BRL) digestion
and subcloned between the corresponding sites in a variant vector of pHN
containing additional restriction sites in the multiple cloning site (pHNb-
CLNX). Mutations in the consensus sites for PKC/PDK in CLNX were
generated using the Quick-Change™ mutagenesis kit (Stratagene). The
introduction of the desired mutation(s) in the plasmid recombinants was
determined by automatic sequencing by the UTHSCA core facility. All
oligonucleotides used to generate mutations were purchased from Operon
Technologies. The CLNX-S485A mutant was generated using the forward
 
primer with sequence 5
 
9
 
-CCTTGTGATCCTCTTCTGCTGTGCTGGA-
AAGAAACAGTCC-3
 
9
 
 and reverse primer with sequence 5
 
9
 
-GGA-
CTGTTTCTTTCCAGCACAGCAGAAGAGGATCACAAGG-3
 
9
 
, and
using as template pHNb-CLNX. The CLNX-S562A mutant was generated
using the forward primer with sequence 5
 
9
 
-GGATGAAATTTTGAA-
CAGAGCACCAAGAAACAGAAAGCCACGAAG- 3
 
9
 
, and the com-
plementary reverse primer with sequence 5
 
9
 
-CTTCGTGGCTTTCT-
GTTTCTTGGTGCTCTGTTCAAAATTTCATCC-3
 
9
 
 and pHNb-CLNX
was again used as template. The double mutant CLNX-S485A/S562A was
generated by exchanging the RsaI to NheI fragment containing the
CLNXS562A mutation for the equivalent wild-type cDNA in the vector
pHNb-CLNXS485A backbone. The presence of both mutations was con-
firmed by sequencing. The CLNX cytosolic peptide was generated by con-
ventional PCR amplification of an internal fragment spanning the S562
PKC consensus site (A537 to the COOH terminus). This primer had se-
quence 5
 
9
 
-ACTGGGATCCATGGATGCTGAAGAAGATGGTGG-3
 
9
 
and incorporated a BamHI site at its 5
 
9
 
 end. The antisense oligonucleotide
had sequence 5
 
9
 
-GCTTAGAGACTCCATTC-3
 
9
 
, which is complemen-
tary to the 3
 
9 
 
untranslated region of 
 
Xenopus
 
 
 
b
 
-globin. The product of this
PCR amplification was digested with BamHI and XbaI and after puri-
fication was subcloned into vector pHNb and similarly digested (plasmid
pHNb-CLNX
 
cyt
 
). The expression vector for SERCA2b has been de-
scribed elsewhere (Camacho and Lechleiter, 1995a; John et al., 1998).
The COOH-terminal domain mutants of SERCA2b and SERCA2b-
N1036A spanning TM segments 9–11 were generated by PCR using as for-
ward primer 5
 
9
 
-ACTGGGATCCATGCCCCCCTGGGAGAACATCT-
GGCTCG-3
 
9
 
 incorporating a BamHI site and as the reverse primer
5
 
9
 
-GCTTAGAGACTCCATTC-3
 
9
 
, which is complementary to the 3
 
9
 
untranslated region of 
 
Xenopus
 
 
 
b
 
-globin present in the template (pHN-
SERCA2b). The PCR products were digested with BamHI and HindIII
and ligated to the similarly digested 
 
Xenopus
 
 expression vector, pHN. The
final constructs encode the COOH terminus of SERCA2b and
SERCA2b-N1036A starting at the methionine residue 924, which is lo-
cated just before TM9 (Bayle et al., 1995). The plasmids were named
pHN-SERCA2b/TM9-11 and pHN-SERCA2b-N1036A/TM9-11. A simi-
lar strategy was followed to generate the SERCA 2a/TM9-10 using as
PCR template plasmid pHN-SERCA2a (John et al., 1998). All vectors
generated were fully sequenced automatically by the core facility at the
UTHSCSA.
 
In Vitro Transcriptions and Oocyte Protocols
 
Synthetic mRNA was prepared as described previously (Camacho and
Lechleiter, 1995a). Plasmids were linearized with NotI, except for plasmid
pHNb-CLNX, which was linearized by NheI digestion. Transcription initi-
ated at the T7 promoter was performed using the Megascript™ high yield
transcription kit and capped with m7G(5
 
9
 
)ppp(5
 
99
 
) (both from Ambion).
All synthetic mRNAs were resuspended at a concentration of 1.5–2.0 
 
m
 
g/
 
m
 
l and stored in aliquots of 3 
 
m
 
l at 
 
2
 
80
 
8
 
C. Stage VI defolliculated oocytes
were injected with a bolus of 50 nl of mRNA using a standard positive
pressure injector (Nanoject; Drummond Scientific). After mRNA injec-
tion, oocytes were cultured for 5–7 d until Ca
 
2
 
1
 
 imaging was performed.
The culture media contained 50% L-15 Media (GIBCO BRL) supple-
mented with antibiotics and was changed daily.
 
Western Blot Analysis
 
Oocyte extracts used in Western blots were prepared from pools of 10 oo-
cytes as described previously (Camacho and Lechleiter, 1995a). To deter-
mine equal loading, membranes were stained with Ponceau S and a single
band was densitometrically analyzed for use as an internal standard for
equal loading in subsequent gels. To detect CLNX the membranes were
probed with the rabbit anti-CLNX antibody (SPA-860; StressGen Bio-
technologies). To detect the SERCA2b antigen, we used a polyclonal rab-
bit anti-SERCA antibody (N1; gift of J. Lytton, University of Calgary
Health Science Center, Calgary, Alberta, Canada). HRP-conjugated sec-
ondary antibodies were used in all Western blots (Jackson Immuno-
Research Laboratories, Inc.) and visualized by enhanced chemilumines-
cence (Pierce Chemical Co.).
 
Immunoprecipitations of 
 
g
 
 -
 
32
 
P–labeled CLNX
 
Groups of oocytes (
 
n
 
 
 
5 
 
30, each) overexpressing the same constructs used
in Ca
 
2
 
1
 
 imaging experiments were injected with a 50-nl bolus of [
 
g
 
-
 
32
 
P]ATP (1:2 dilution of a 150-mCi/mL stock; 6,000 Ci/mM; New England
Biolabs, Inc.). After a 10-min period of equilibration, half of the oocytes
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in each group were injected with IP
 
3
 
 (
 
z
 
300 nM final; Calbiochem). Oo-
cytes were instantly frozen on dry ice 6 min after the IP
 
3
 
 injection. During
these treatments, oocytes were maintained in ND96 buffer which con-
tained 1 mM EGTA, 96 mM NaCl, 2 mM KCl, 2 mM MgCl
 
2
 
, 5 mM Hepes,
pH 7.5. Membrane extracts were prepared as follows: oocytes were ho-
mogenized in lysis buffer (40 mM Tris-HCl, pH 7.5, 50 mM NaCl, 10 mM
MgCl
 
2
 
, 2 mM EDTA, 0.5 mM EGTA) supplemented with phosphatase in-
hibitors (10 mM NaF, 0.4 mM Na
 
3
 
VO
 
4
 
, 0.1 mM ZnCl
 
2
 
, 1 mM NaPP
 
i
 
) and
the protease inhibitors (2 mM PMSF, 20 
 
m
 
M leupeptin, and 150 
 
m
 
M pep-
statin A final). The oocytes were extracted twice in volumes of 300 
 
m
 
l,
with the particulate fraction being removed by centrifugation at 10,000 
 
g
 
for 15 s between each extraction. The membrane fraction was isolated by
centrifugation for 1 h at 100,000 
 
g
 
. Membrane proteins were extracted at
room temperature in solubilization buffer (10 
 
m
 
l per oocyte) consisting of
lysis buffer containing 1% IGEPAL (Sigma Chemical Co.) and 1% SDS
for 20 min. The soluble fraction was then isolated by centrifugation at
10,000 
 
g
 
 for 5 min. After a fivefold dilution in lysis buffer, 10 
 
m
 
l of a 50%
suspension of protein A–Sepharose (pretreated by incubation 3 
 
3
 
 20 min
in 5% BSA) was added to the membrane fraction. After over-end rotation
at room temperature for 2 h, the protein A–Sepharose was removed by
centrifugation. The CLNX antibody was added at a dilution of 1:250 and
incubated with over-end rotation at 4
 
8
 
C overnight. To the cell lysate, 8 
 
m
 
l
of the 50% suspension of pretreated protein A–Sepharose was added and
incubated with over-end rotation for 1 h at room temperature. The im-
mune complexes were washed three times with lysis buffer containing 1%
IGEPAL and harvested by centrifugation and eluted from the protein
A–Sepharose by boiling for 4 min in Laemmli SDS sample buffer. The
proteins were separated by SDS-PAGE through an 8% gel. After the gel
was fixed and dried, the proteins were visualized by autoradiography.
 
In Vitro Translations and Glycosylation Analysis
 
Messenger RNA was diluted to 0.1 
 
m
 
g/
 
m
 
l and translated for 45 min in a
rabbit reticulocyte lysate translation system supplemented with canine
pancreatic microsomes and L-[
 
35
 
S]methionine according to the instruc-
tions of the manufacturer (Promega). To prevent further initiation of
translation, m7G(5
 
9
 
)ppp(5
 
99
 
) (Ambion) was added to a final concentra-
tion of 2 mM and incubated for 5 min at 30
 
8
 
C. Nascent chains were re-
leased from ribosomes by treatment with puromycin (Fisher Scientific),
which was added to a concentration of 1 mM and incubated for 5 min at
30
 
8
 
C. To inhibit ongoing translation, emetine (Sigma Chemical Co.) was
added to a final concentration of 2 mM and incubated on ice for 5 min. Fi-
nally, the microsomal fraction was isolated by ultracentrifugation at
125,000 
 
g 
 
for 12 min through a high salt–sucrose cushion using a Beckman
Optima TLX ultracentrifuge in a TLA 45 rotor (Oliver et al., 1996).
To determine whether the COOH terminus of SERCA2b was glyco-
sylated, microsomes were isolated from in vitro translation reactions pro-
grammed with appropriate mRNAs as described above. The isolated mi-
crosomes were solubilized by boiling in endo H denaturing buffer (New
England Biolabs, Inc.) for 10 min. To half of each reaction, one tenth vol-
ume of 10
 
3
 
 G5 buffer and 1 
 
m
 
l of endo H
 
f
 
 was added and incubated at
37
 
8
 
C for 2 h. The samples were then subjected to SDS-PAGE and fluorog-
raphy.
 
Coimmunoprecipitations and Dephosphorylations
 
Microsomes from the mRNA-programmed translations were solubilized
in immunoprecipitation lysis buffer containing 1% Triton X-100, 10 mM
Tris-HCl, pH 7.6, 140 mM NaCl, 0.2 mM [4-(zaminoethyl)benzene sulfo-
nylfluoride, HCl] (AEBSF; Calbiochem) for 45 min at 4
 
8
 
C. After centrifu-
gation at 16,000 
 
g
 
,
 
 
 
the supernatant was retained, diluted fivefold in immu-
noprecipitation buffer without Triton X-100 and precleared by incubation
with 10 
 
m
 
l of a 50% suspension of protein A/G PLUS agarose (Santa Cruz
Biotechnology, Inc.) with over-end rotation at 4
 
8
 
C for 1 h. The agarose
was discarded after centrifugation at 1000 
 
g
 
 for 5 min. To the supernatant,
3 
 
ml of anti-CLNX antibody (C3; gift of J. Bergeron, McGill University,
Montreal, Canada) was added and incubated with over-end rotation at
48C overnight. Protein A/G PLUS agarose (20 ml of a 50% suspension)
was added and incubated with over-end rotation at 48C for 1 h. The im-
mune complexes were harvested by centrifugation at 1,000 g for 5 min and
washed twice with immunoprecipitation buffer containing 0.1% Triton
X-100 and once without Triton X-100. The immune complexes were re-
suspended in sample buffer containing 38 mM DTT to denature the pro-
teins, boiled for 5 min and subjected to 15% SDS-PAGE. The gels were
fixed, incubated in Amplify™ (Amersham Pharmacia Biotech), dried, and
visualized by fluorography.
For dephosphorylation reactions, microsomes from the SERCA2b/
TM9-11 or the SERCA2b-N1036A/TM9-11 translations were resus-
pended in 50 ml of immunoprecipitation buffer containing 2 mM MgCl2
without Triton X-100. 5 U (1 U/ml) of calf intestinal alkaline phosphatase
(Boehringer) was added and dephosphorylation was allowed to proceed
at 308C for 20 min. The microsomes were isolated by centrifugation
through a high salt/sucrose cushion and processed for coimmunoprecipita-
tion and SDS-PAGE as described above. All coimmunoprecipitations and
dephosphorylation experiments were performed on at least three inde-
pendent occasions, and the standard error bars are indicated for densito-
metric measurements on the corresponding figures.
Confocal Imaging of Intracellular Ca21
Ca21 wave activity was imaged with the fluorescent Ca21 indicator, Ore-
gon green I (12.5 mM final concentration assuming an oocyte volume of 1
ml) (Molecular Probes, Inc.). With exception to experiments using pyru-
vate malate–treated oocytes, confocal imaging was performed using a
NORAN OZ confocal laser scanning microscope at zoom 0.7 attached to
a Nikon 200 Eclipse inverted microscope. A 203 (0.75 NA) water immer-
sion Nikon objective was used and images were collected at 0.5-s intervals.
The confocal slit was set at 50 mm. Confocal imaging of pyruvate malate–
treated oocytes was performed using a Zeiss confocal laser scanning
microscope (LSM310) at zoom 2 attached to a Zeiss upright Axioplan mi-
croscope. A 103 objective was used and images were collected at 0.5-s in-
tervals. Images were analyzed with ANALYZE software (Mayo Founda-
tion) on a Silicon Graphics O2 workstation. Ca21 increases were initiated
by injection of a 50-nl bolus of 6 mM IP3 (z300 nM final) (Calbiochem).
All images were acquired in ND96 containing 1 mM EGTA (Sigma
Chemical Co.) without extracellular Ca21.
Statistical Analysis
Statistical significance was determined by using the t test and the Chi-
square test where appropriate. Significance level was accepted at P ,
0.05.
Results
Overexpression of CLNX in Xenopus Oocytes Inhibits 
Intracellular Ca21Oscillations
Although CRT has been shown to modulate different as-
pects of Ca21 signaling (Bastianutto et al., 1995; Mery et
al., 1996; Coppolino et al., 1997; Fasolato et al., 1998; John
et al., 1998; Roderick et al., 1998; Mesaeli et al., 1999),
most of these effects were attributed to CRT’s ability to
bind Ca21 with high capacity (Baksh and Michalak, 1991;
Bastianutto et al., 1995; Mery et al., 1996; Coppolino et al.,
1997; Fasolato et al., 1998; Roderick et al., 1998; Mesaeli et
al., 1999). However, we demonstrated by deletion mu-
tagenesis that the inhibition of Ca21 waves observed when
CRT is overexpressed in Xenopus oocytes survives dele-
tion of the high capacity Ca21 binding C-domain (Ca-
macho and Lechleiter, 1995a; John et al., 1998). Since
CLNX shares homology to CRT on the P-domain and
both have been characterized as lectin chaperones, we
tested whether CLNX would also modulate Ca21 oscilla-
tions. CLNX-overexpressing oocytes injected with IP3
(300 nM final) were imaged confocally 5 d after mRNA in-
jection. Very few of these oocytes exhibited Ca21 oscilla-
tions (12%; n 5 17). These oscillations are rarely observed
in control, nonoverexpressing oocytes after 6 d of culture
(17%; n 5 18). Thus, we tested the effects of CLNX over-
expression under conditions that reliably elicit robust Ca21
oscillations (i.e., overexpression of SERCA pumps or
energization of mitochondria with pyruvate/malate)
(Camacho and Lechleiter, 1993, 1995a; John et al., 1998;
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Jouaville et al., 1995). Compared with oocytes overex-
pressing SERCA2b alone, oocytes coexpressing CLNX 1
SERCA2b displayed inhibition of high frequency Ca21 os-
cillations (Fig. 1 a). A large percentage of oocytes overex-
pressing SERCA2b alone exhibited high-frequency repeti-
tive Ca21 waves (88%; n 5 52), whereas this percentage
was significantly lower in CLNX 1 SERCA2b oocytes
(30%; n 5 63) (Fig. 1 b, left, and Table I). In addition, in
comparison to SERCA2b-overexpressing oocytes, CLNX 1
SERCA2b coexpressing oocytes appear to have a more
rapid initial rise in cytosolic Ca21, suggesting that in these
Figure 1. Overexpression of CLNX in Xenopus oocytes inhibits
repetitive Ca21 waves. (a) Confocal Ca21 imaging in a control oo-
cyte overexpressing rat SERCA2b shows high frequency Ca21
oscillations after an injection of IP3 (z300 nM final). Inhibition
of Ca21 oscillations is also shown for a representative oocyte co-
expressing CLNX 1 SERCA2b. In this and subsequent figures,
the top image contains a spatio–temporal stack of Ca21 wave ac-
tivity followed to the right by a representative confocal image of
Ca21 wave activity at the indicated timepoint. Bar, 50 mm. Also in
this and subsequent figures, the trace under each image repre-
sents the change in fluorescence from resting levels (DF/F) shown
as a function of time. The white square represents the 5 3 5 pixel
area used in determining DF/F. (b) The percentage of oocytes ex-
hibiting repetitive Ca21 wave activity was decreased in oocytes
coexpressing CLNX 1 SERCA2b (n 5 63, 30%), relative to oo-
cytes overexpressing SERCA 2b alone (n 5 52, 88%) (left). The
asterisk indicates statistical significance in comparison to oocytes
overexpressing SERCA2b alone, P , 0.005 (Chi-square test). In
this figure and subsequent histograms, the color convention used
is as follows: black for SERCA 2b and light gray for CLNX 1
SERCA2b overexpressing oocytes. Detailed analysis of Ca21
waves was performed only on those oocytes that exhibited re-
petitive Ca21 waves. Compared with oocytes overexpressing
SERCA 2b alone, overexpression of CLNX 1 SERCA2b in-
creased the period between waves (middle) and the decay time of
individual waves (right). The asterisk denotes a statistical signifi-
cant difference P , 0.05 (t test) in comparison to control oocytes
overexpressing SERCA2b alone (see also Table I).
Figure 2. Overexpression of CLNX in Xenopus oocytes inhibits
repetitive Ca21 waves induced by mitochondrial energization. (a)
Confocal Ca21 imaging of a control oocyte (IP3 z300 nM final)
energized previously with pyruvate malate (10 mM final). In this
representative oocyte, a Ca21 tide is followed by low-frequency
Ca21 oscillations. Ca21 oscillations are inhibited in a representa-
tive oocyte overexpressing CLNX. Bar, 100 mm. (b) The percent-
age of oocytes exhibiting repetitive Ca21 wave activity was de-
creased in oocytes overexpressing CLNX (n 5 18, 71%), relative
to control oocytes (n 5 25, 84%) (left). The asterisk indicates sta-
tistical significance in comparison to oocytes overexpressing
SERCA2b alone, P , 0.05 (Chi-square test). Detailed analysis of
Ca21 waves was performed only on those oocytes that exhibited
repetitive Ca21 activity. Compared with control oocytes, overex-
pression of CLNX increased the period between waves (middle)
and the decay time of individual waves (right). The asterisk de-
notes a statistical significant difference P , 0.05 (t test) in com-
parison to control oocytes (see also Table II).
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oocytes, rapid amplification of Ca21 release occurs be-
cause the Ca21 ATPase is inhibited. Therefore, we per-
formed measurements of interwave period and decay time
of individual waves (t1/2), which reflect the Ca21 uptake
process (John et al., 1998). Compared with control oocytes
overexpressing SERCA2b alone, oocytes coexpressing
CLNX 1 SERCA2b had statistically significant longer in-
terwave periods and longer decay times for individual
waves (Fig. 1 b, middle and right, and Table I).
Energization of mitochondria by injection of pyruvate
malate (10 mM final) results in a Ca21 tide followed by ro-
bust, low-frequency Ca21 waves (Fig. 2 a). Overexpression
of CLNX alone in oocytes injected with pyruvate malate
results in inhibition of Ca21 oscillations. Specifically, the
percentage of oocytes displaying oscillations was signifi-
cantly reduced by CLNX overexpression in relation to
control nonoverexpressing oocytes (Fig. 2 b, left, and Ta-
ble II). More importantly, interwave periods and decay
times for individual waves were significantly increased in
CLNX-overexpressing oocytes (Fig. 2 b, middle and right,
and Table II).
The functional interaction of CRT with SERCA2b re-
quires the presence of a luminal asparagine in the pump
(John et al., 1998). To determine whether the mechanism
of inhibition by CLNX also involves this asparagine, we over-
expressed SERCA2b-N1036A and compared these oo-
cytes to oocytes coexpressing CLNX 1 SERCA2b-N1036A
(Fig. 3). High-frequency repetitive Ca21 waves without a
preceding tide were observed in all of these oocytes (Table
I). As was the case with CRT (John et al., 1998), CLNX
did not inhibit Ca21 oscillations when coexpressed with
SERCA2b-N1036A. Thus, the percentage of oocytes ex-
hibiting repetitive Ca21 wave activity was unchanged in
oocytes coexpressing CLNX (n 5 19; 100%), relative to
control oocytes (n 5 20; 100%) (Table I). In addition,
there is no statistical difference between SERCA2b-N1036A
and CLNX 1 SERCA2b-N1036A overexpressing oocytes
in interwave periods (Table I). Thus, both members of this
family of chaperones appear to functionally interact with
SERCA2b, and mutagenesis of the lumenal asparagine in-
terferes with the manifestation of this inhibitory effect.
CLNX Physically Interacts with the COOH Terminus 
of SERCA2b
In the preceding experiments we demonstrated a func-
tional interaction between CLNX and SERCA2b but not
with SERCA2b-N1036. In the modulation of protein fold-
ing, CLNX has been shown to interact with substrates by
two mechanisms, either by a lectin interaction with the
monoglucosylated N-linked glycans, or by a more classical
chaperone protein–protein interaction (Helenius et al.,
1997; Ihara et al., 1999). Thus, our results with the N1036A
mutant could be attributed either to the removal of the
N-linked glycan or to a change in charge, which under-
mines the interaction of the Ca21 ATPase with CLNX. To
characterize this interaction, we first determined whether
SERCA2b is glycosylated. We generated constructs en-
coding the COOH terminus of SERCA2b and its N1036A
mutant starting at TM9 (i.e., SERCA2b/TM9-11 and
SERCA2b-N1036A/TM9-11), as well as of SERCA2a/
TM9-10 to use as control (Gunteski-Hamblin et al., 1988).
Correct polytopic insertion of the translation products in
the ER membrane has been demonstrated previously for
similar constructs in microsomes (Bayle et al., 1995). After
mRNA synthesis, translation was performed in rabbit
reticulocyte lysate in the presence of canine pancreatic mi-
crosomes. All constructs were efficiently translated and
run at the correct predicted molecular masses (SERCA2b
and SERCA2b-N1036A/TM9-11, z13.2 kD; and SERCA2a
z7.2 kD). Posttranslational processing was observed on a
Table I. Detailed Analysis of Ca21 Wave Activity in Oocytes that Exhibited Repetitive Ca21 Waves
Oocytes per group Oocytes displaying oscillations Wave Period Decay Time
n % s s
SERCA2b 52 88.0 2.49 6 0.01 0.62 6 0.01
CLNX 1 SERCA2b 63 30.0* 3.13 6 0.02* 0.93 6 0.01*
CLNX-S562A 1 SERCA2b 36 92.0‡ 3.06 6 0.02 0.73 6 0.01‡
CLNX-S485A 1 SERCA2b 27 15.0 3.45 6 0.04 1.05 6 0.02
CLNX-S562A/S485A 1 SERCA2b 34 26.5 3.42 6 0.02 1.07 6 0.01§
CLNXcyt 1 CLNX 1 SERCA2b 18 72.0i 2.97 6 0.03 0.79 6 0.01i
SERCA2b-N1036A 20 100 1.88 6 0.01¶ 0.35 6 0.002
CLNX 1 SERCA2b-N1036A 19 100 2.10 6 0.03 0.46 6 0.007**
Mean 6 SEM. n, total number of oocytes per category. Percentage is the percent of n. The statistical significance was analyzed with a Chi-square test for comparisons related to
the percentage of oocytes displaying oscillations (P , 0.005). All other comparisons were tested for statistical significance using t test, and P values are indicated.
*CLNX 1 SERCA2b is not equivalent to SERCA2b (P , 0.005).
‡CLNX-S562A 1 SERCA2b is not equivalent to CLNX 1 SERCA2b (P , 0.01).
§CLNX-S562A/S485A 1 SERCA2b is not equivalent to CLNX 1 SERCA2b (P , 0.05).
iCLNXcyt 1 CLNX 1 SERCA2b is not equivalent to CLNX 1 SERCA2b (P , 0.05).
¶SERCA2b-N1036A is not equivalent to SERCA2b (P , 0.05).
**SERCA2b-N1036A is not equivalent to CLNX 1 SERCA2b-N1036A (P , 0.05).
Table II. Analysis of Ca21 Wave Activity in Pyruvate
Malate–treated Oocytes that Exhibited Repetitive Ca21 Waves
Oocytes
per group
Oocytes
displaying
oscillations Wave Period Decay Time
n % s s
Control 25 84 20.55 6 0.45 3.41 6 0.06
CLNX 18 71* 29.49 6 0.57* 5.39 6 0.09*
Mean 6 SEM. n, total number of oocytes per category. Percent is the percent of n. The
statistical significance was analyzed with a Chi-square test for comparisons related to
the percentage of oocytes displaying oscillations (P , 0.005). All other comparisons
were tested for statistical significance using t test, and P values are indicated.
*CLNX is not equivalent to control (P , 0.05).
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protein glycosylated on three asparagine residues that
served as positive control (glycosylated S. cerevisiae a fac-
tor, z30 kD). SERCA2b and the N1036A mutant migrate
at a similar rate, indicating that SERCA2b might not be
glycosylated (Fig. 4 a). To corroborate this, we treated
in vitro translated SERCA2b/TM9-11 and SERCA2b-
N1036A/TM9-11 products with endoglycosidase H (endo
H). Under the experimental conditions, S. cerevisiae a fac-
tor underwent de-glycosylation by endo H (Fig. 4 b). How-
ever, endo H treatment did not alter the mobility of
SERCA2b/TM9-11 or of SERCA2b-N1036A/TM9-11, in-
dicating that SERCA2b is not glycosylated.
Since CLNX has been shown to interact also via pro-
tein–protein interactions regardless of whether the sub-
strate is glycosylated (Ihara et al., 1999), the possibility
remained that CLNX would interact with the COOH ter-
minus of SERCA2b. To test this hypothesis, we performed
coimmunoprecipitations in which endogenous CLNX
present in the pancreatic microsomes was immunoprecipi-
tated with a CLNX-specific antibody. Coimmunoprecipi-
tated proteins were subsequently detected by fluorog-
raphy. SERCA2b, and to a significantly lower extent,
SERCA-N1036A were coimmunoprecipitated (0.61 6
0.02, P , 0.005, n 5 5) (Fig. 4 c). More importantly, no in-
teraction with the COOH terminus of SERCA2a was de-
Figure 3. CLNX does not inhibit Ca21 oscillations induced by
overexpression of the SERCA2b-N1036A mutant. Confocal
Ca21 imaging in an oocyte overexpressing SERCA2b-N1036A
after an injection of IP3 (z300 nM final) shows high-frequency
Ca21 oscillations (top). These oscillations are not inhibited in oo-
cytes coexpressing CLNX 1 SERCA2b-N1036A (bottom). Bar,
50 mm.
Figure 4. CLNX coimmunoprecipitates with the COOH termi-
nus of SERCA2b. In vitro translations of synthetic mRNAs were
performed in rabbit reticulocyte lysate supplemented with canine
pancreatic microsomes and L-[35S]methionine. Samples were
subjected to 15% SDS-PAGE and detected by fluorography. (a)
Membrane fractions isolated from in vitro translation reactions
were loaded as follows: S. cerevisiae a factor (lane 1), negative
control without RNA (lane 2), SERCA2a/TM9-10 (lane 3),
SERCA2b/TM9-11 (lane 4), and SERCA2b-N1036A/TM9-11
(lane 5). (b) Endo H treatment demonstrates that the COOH ter-
minus of SERCA2b is not glycosylated. Samples were loaded as
follows: negative control without mRNA (lane 1), paired samples
were loaded 6 endo H as follows: S. cerevisiae a factor (second
set of lanes), SERCA2b/TM9-11 (third set of lanes), SERCA2b-
N1036A/TM9-11 (fourth set of lanes), and SERCA2a/TM9-10
(fifth set of lanes). (c) Coimmunoprecipitations of CLNX with
SERCA COOH terminus constructs demonstrates an interaction
of CLNX with SERCA2b, a reduced interaction with the
SERCA2b-N1036A mutant, but no interaction with SERCA2a.
Lanes were loaded as follows: negative control without RNA in
the translation (lane 1), S. cerevisiae a factor (lane 2), SERCA2a/
TM11-10 (lane 3), SERCA2b/TM9-11 (lane 4), and SERCA2b-
N1036A/TM9-11 (lane 5).
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tected. Finally, the S. cerevisiae a factor was efficiently
coimmunoprecipitated, indicating that a lectin interaction
with CLNX may be at play. These results demonstrate that
CLNX specifically interacts with SERCA2b and that mu-
tagenesis of N1036 in SERCA2b drastically interferes with
this interaction, possibly by changing the charge at the
COOH terminus of the Ca21 ATPase.
Phosphorylation in the Cytosolic Domain of CLNX 
Regulates the Inhibition of Ca21 Oscillations
Stimulation of the IP3-mediated Ca21 signaling cascade ac-
tivates PKC, which subsequently phosphorylates down-
stream targets (Berridge and Irvine, 1989; Berridge, 1993;
Newton, 1995). The presence of consensus sites for phos-
phorylation by PKC/PDK in the cytosolic domain of CLNX
raises the possibility that their state of phosphorylation
modulates ER lumenal interactions with SERCA2b. To
test this hypothesis, we first generated mutants of CLNX
in which PKC/PDK consensus phosphorylation sites were
changed to unreactive alanines (Fig. 5). We then confo-
cally imaged IP3-induced Ca21 release in oocytes that were
coexpressing these CLNX mutants with SERCA2b, and
compared their activity to oocytes coexpressing wild-type
CLNX 1 SERCA2b. Interestingly, the CLNX-S562A
mutant did not inhibit Ca21 oscillations (Fig. 6 a). The
percentage of oocytes overexpressing CLNX-S562A 1
SERCA2b that exhibited Ca21 oscillations was indis-
tinguishable from that of control oocytes overexpress-
ing SERCA2b alone, and more importantly, was signifi-
cantly greater than that of oocytes coexpressing wild-type
CLNX 1 SERCA2b (Fig. 6 b and Table I). These results
suggest that phosphorylation of the distal conserved PKC
phosphorylation site regulates the inhibition of Ca21 oscil-
lations from the cytosol.
To determine whether the second PKC phosphorylation
consensus site is functional, we overexpressed CLNXS
485A 1 SERCA2b in oocytes. In contrast to what was ob-
served with the CLNX-S562A mutant, repetitive Ca21 waves
were inhibited in oocytes overexpressing CLNX-S485A 1
SERCA2b (n 5 27, 85%) (Fig. 6 and Table I). This per-
centage does not differ significantly from that obtained for
oocytes overexpressing CLNX 1 SERCA2b. This obser-
vation is consistent with two hypothetical scenarios. The
S485 residue is not functional and the inhibition of Ca21
oscillations can be attributed solely to the distal phosphor-
ylated S562, or S485 is required for the regulation of Ca21
oscillations by S562. To determine which of these two hy-
potheses was correct, we generated a double mutant in
which both serine residues were mutated to alanines
(mutant CLNX-S485A/S562A) (Fig. 5). Ca21 wave activity
was imaged in oocytes either coexpressing CLNX-S485A/
S562A 1 SERCA2b or overexpressing SERCA2b by itself
(Fig. 6 and Table I). Ca21 oscillations were inhibited in the
CLNX-S485A/S562A 1 SERCA2b coexpressing oocytes,
suggesting that S485 enables regulation of repetitive Ca21
waves by the S562 residue. Furthermore, the data are con-
sistent with the modulation of Ca21 oscillations by CRT
reported previously (Camacho and Lechleiter, 1995a), in
that the double CLNX mutant displays constitutive chap-
erone properties that are not regulated by cytosolic phos-
phorylation. Taken together, our results reveal the pres-
ence of a phosphorylation-dependent regulatory switch in
the S562 residue of CLNX.
A Cytosolic Domain Peptide of CLNX Removes the 
Inhibition of Ca21 Oscillations
A dominant-negative experimental approach was adopted
to further implicate an endogenous kinase/phosphatase
operating on S562. We hypothesized that coexpression of
CLNX with a peptide encompassing the distal PKC/PDK
consensus site would compete with the responsible kinase/
phosphatase to abrogate the inhibitory effect of CLNX on
Figure 5. Mutagenesis of consensus sites for phosphorylation by PKC/PDK in CLNX. The ER lumenal, single TM, and cytosolic do-
main boundaries for CLNX are indicated. Partial sequence of the cytosolic domain is shown in single letter amino acid code. PKC phos-
phorylation consensus sites are indicated in bold and underline. Specific phosphorylated residues are shown in larger font and depicted
as filled circles. Sequence mutations generated are indicated in amino acid code and depicted by clear circles. The full sequence and po-
sition relative to wild-type CLNX is shown for the CLNXcyt cytosolic peptide. To the right of each construct, the corresponding symbol
is given and is used in subsequent figures.
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Ca21 oscillations. Thus, we engineered a Xenopus vector
for expression of a cytosolic CLNX peptide, encompassing
amino acids 534–571 of mature rat CLNX (CLNXcyt). In
these experiments, oocytes were injected with mRNA en-
coding wild-type CLNX 1 SERCA2b. 18 h before imaging
of Ca21 wave activity, mRNA encoding CLNXcyt was in-
jected into half of the experimental oocytes. As predicted,
coexpression of the peptide with full-length CLNX 1
SERCA2b resulted in the abrogation of the inhibitory ef-
fects imparted by wild-type CLNX (Fig. 7 a). The percent-
age of oocytes exhibiting repetitive Ca21 waves increased
from 30% in CLNX 1 SERCA2b coexpressing oocytes to
72% in oocytes that, in addition, coexpressed CLNXcyt
(n 5 18) (Fig. 7 b and Table I). Thus, the cytosolic peptide
successfully competes for the endogenous cytosolic kinase/
phosphatase that determines the phosphorylation status of
S562 and the regulation of Ca21 oscillations.
Figure 6. Inhibition of repetitive Ca21 waves is abrogated by a
single amino acid mutation in serine residue 562 of CLNX. (a)
Changes in fluorescence from resting levels (DF/F) are shown for
oocytes as labeled. To the right of each trace, a single confocal
image of Ca21 wave activity at the indicated time is shown for
each representative oocyte. (b) The percentage of oocytes exhib-
iting repetitive Ca21 wave activity in oocytes coexpressing
CLNX-S562A 1 SERCA2b is increased from that of the wild-
type CLNX, and reaches the levels of SERCA2b alone control
oocytes (depicted as a dashed line). This percentage was not sig-
nificantly different in oocytes overexpressing the proximal PKC
mutant CLNX-S485A 1 SERCA2b or the double mutant
CLNX-S485A/S562A 1 SERCA2b when compared with oocytes
overexpressing wild-type CLNX 1 SERCA2b. The asterisk de-
notes a statistical significant difference (P , 0.005, Chi-square)
for the comparison of CLNX-S562A mutant to wild-type CLNX.
Figure 7. Dominant-negative expression of a competing peptide
spanning serine residue 562 of CLNX reverses the inhibition of
Ca21 oscillations by the wild-type protein. (a) DF/F is shown for a
representative control oocyte coexpressing CLNX 1 SERCA2b
(upper panel) and for an oocyte overexpressing CLNXcyt 1
CLNX 1 SERCA2b (lower panel). To the right of each trace, a
corresponding single confocal image of Ca21 wave activity is
shown. (b) The percentage of oocytes exhibiting repetitive Ca21
wave in oocytes coexpressing CLNX 1 SERCA2b 1 CLNXcyt is
increased when compared with oocytes in which the cytosolic
peptide was omitted (CLNX 1 SERCA2b). The asterisk indi-
cates statistical significance of P , 0.005 (Chi-square) for a com-
parison between oocytes overexpressing CLNXcyt 1 CLNX 1
SERCA2b and control oocytes in which the cytosolic peptide was
omitted.
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IP3-mediated Ca21 Mobilization Causes 
Dephosphorylation of the Cytosolic Domain of CLNX
Having established the unique contribution of CLNX resi-
due S562 in the inhibition of Ca21 oscillations, we deter-
mined the state of phosphorylation of wild-type and
CLNX-S562 before and after mobilization of Ca21 by IP3.
This was accomplished by first injecting [g-32P]ATP into
oocytes that were coexpressing CLNX or its S562A mu-
tant, with SERCA2b. Half of the oocytes for each exper-
imental condition was subsequently injected with IP3
(z300 nM final). Immunoprecipitations with a CLNX-spe-
cific antibody were then carried out. Similar measure-
ments were also performed in oocytes coexpressing the
cytosolic peptide CLNXcyt with wild-type CLNX (Fig. 8
a). In control oocytes overexpressing SERCA2b alone,
CLNX was not detected. Interestingly, CLNX was phos-
phorylated under resting conditions and was dephos-
phorylated by IP3-mediated mobilization of Ca21. Basal
phosphorylation of the S562A mutant was less than half of
wild-type CLNX and was not changed by IP3 injection.
These observations suggest first that the S562 residue is
phosphorylated, and second that the Ca21-sensitive de-
phosphorylation of CLNX is specific for this residue. Un-
der resting conditions, phosphorylation of CLNX was
slightly reduced by coexpression with the CLNXcyt pep-
tide, and after IP3 injection, there was a further reduction
in the level of phosphorylation seen. This suggests that the
function of the CLNXcyt peptide was to compete with the
phosphatase activity responsible for CLNX dephosphory-
lation. Data from oocytes expressing the S485A and
S485A/S562A mutants of CLNX are not shown, since the
level of phosphate label detected was too low to reliably
demonstrate the phosphorylation status of either mutant,
consistent with the report by Wong et al. (1998).
Western blot analysis with an anti-CLNX antibody was
performed on oocyte fractions coexpressing CLNX or its
PKC/PDK phosphorylation mutants, with SERCA2b (Fig.
8 b). A single band migrating at z90 kD was observed in
membrane extracts prepared from oocytes overexpressing
CLNX or its mutants, consistent with the reported molecu-
lar weight for CLNX (Wada et al., 1991). Thus, the differ-
ences in intensity of phosphorylated CLNX and its mutants
cannot be attributed to differences in overexpression lev-
els. In control oocyte extracts overexpressing SERCA2b
alone, no detectable CLNX immunoreactivity was ob-
served. To determine whether SERCA2b was coexpressed
with CLNX, we probed oocyte extracts with an anti–rat
SERCA2b antibody (John et al., 1998). SERCA2b overex-
pression was demonstrated in all extracts (Fig. 8 c). We ob-
served no significant differences in SERCA2b immunore-
activity. When small variations did occur, they did not
correlate with the presence or absence of Ca21 oscillations.
In particular, notice that the SERCA2b immunoreactivity
detected in extracts from CLNX-S562A 1 SERCA2b
overexpressing oocytes was slightly lower, but these levels
of SERCA2b expression did not correlate with a decrease
in the frequency of Ca21 oscillations.
The Interaction of CLNX with SERCA2b Is Reduced 
by Dephosphorylation Treatment
To determine whether cytosolic dephosphorylation of
Figure 8. CLNX is dephosphorylated after IP3 injection. (a)
Immunoprecipitations of [g-32P]ATP-labeled CLNX and CLNX-
S562A mutant from oocytes injected with IP3 (1) or noninjected
(2) control oocytes run on SDS-PAGE (upper panel). Paired
samples were loaded 6 IP3 for oocytes overexpressing the fol-
lowing: SERCA2b alone (first set of lanes), CLNX 1 SERCA2b
(second set of lanes), CLNX-S562A 1 SERCA2b (third set of
lanes), and CLNXcyt 1 CLNX 1 SERCA2b (fourth set of lanes).
Densitometric analysis of the phosphorylated protein bands was
normalized to the intensity of the wild-type CLNX (2IP3) and
plotted in arbitrary units (lower panel). (b) Immunodetection of
CLNX detected by Western blotting in oocytes overexpressing
the following: CLNX and CLNX mutants with SERCA2b (upper
panel). The gel was loaded as follows: SERCA2b (lane 1),
CLNX 1 SERCA2b (lane 2), CLNX-S485A/S562A 1
SERCA2b (lane 3), CLNX-S485A 1 SERCA2b (lane 4), and
CLNX-S562A 1 SERCA2b (lane 5). Immunodetection of
SERCA2b in oocytes coexpressing SERCA2b with CLNX and
CLNX mutants (lower panel). The lanes correspond to protein
fractions from oocytes that were injected with mRNAs encoding
the following: SERCA2b (lane 1), CLNX 1 SERCA2b (lane 2),
CLNX-S562A 1 SERCA2b (lane 3), CLNX-S485A 1
SERCA2b (lane 4), and CLNX-S485A/S562A 1 SERCA2b
(lane 5).
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CLNX affects its interaction with SERCA2b, we immuno-
precipitated endogenous CLNX from microsomes treated
with alkaline phosphatase and detected proteins bound to
CLNX by fluorography (Fig. 9). Calf intestinal phos-
phatase removes phosphate groups from phosphoserine
and phosphothreonine residues, which accounts for .97%
of phosphate bound to eukaryotic cells. The microsomes
were isolated from translation reactions programmed to
express the COOH terminus of SERCA2b (TM9-11) and
S. cerevisiae a factor as a positive control. Interestingly, al-
kaline phosphatase treatment significantly reduced the
coimmunoprecipitation of both substrates with CLNX,
suggesting that in the dephosphorylated state CLNX no
longer associates with the SERCA2b substrate.
Discussion
In this study, we demonstrated that CLNX overexpression
in Xenopus oocytes modulates IP3-mediated Ca21 oscilla-
tions. As observed for CRT, modulation of Ca21 release is
manifested by an inhibition of repetitive Ca21 waves in a
manner consistent with inhibition of SERCA2b activity
(Camacho and Lechleiter, 1995a; John et al., 1998). More
importantly, unlike the modulation by CRT, the inhibition
of Ca21 oscillations by CLNX is subject to regulation by
the phosphorylation status of its cytosolic domain.
Store refilling by SERCA pumps is the predominant
factor that controls the frequency of Ca21 oscillations (Ca-
macho and Lechleiter, 1993). Consistent with this, we find
that overexpression of SERCA2b alone results in z90%
of oocytes exhibiting high-frequency Ca21 waves, whereas
coexpression of CLNX 1 SERCA2b reduces this num-
ber to 30%. Detailed analysis of Ca21 wave activity in
CLNX 1 SERCA2b overexpressing oocytes that did not
show complete inhibition also revealed an effect consis-
tent with inhibition of the Ca21 ATPase. Specifically, we
found statistically significant increases in wave periods and
the t1/2 decay of individual waves when CLNX was coex-
pressed with SERCA2b. Both of these parameters are in-
dicators of the refilling process. Furthermore, the inhibi-
tion of Ca21 oscillations was equally manifested regardless
of whether the oscillations were generated by overexpres-
sion of SERCA2b pumps or whether mitochondria were
energized.
We have shown previously that CRT inhibition of Ca21
oscillations is dependent on the presence of a lumenal as-
paragine in SERCA2b (N1036), which appeared to be tar-
geted by the chaperone (John et al., 1998). Here we found
that in oocytes coexpressing CLNX 1 SERCA2b-N1036,
Ca21 oscillations were not inhibited, suggesting that both
members of this family of proteins inhibit Ca21 oscillations
by similar mechanisms. We found that there is a physi-
cal interaction of CLNX with the COOH terminus of
SERCA2b which is reduced by mutagenesis on N1036A
and is not at all existent with SERCA2a. This reduction in
the interaction may be due to a change in charge induced
by mutagenesis of SERCA2b-N1036A, since we found no
evidence that SERCA2b was glycosylated on N1036. To-
gether, these results raise the possibility that CLNX inhibi-
tion of Ca21 oscillations is due to a protein–protein inter-
action with the COOH terminus of SERCA2b. Recently,
Ihara et al. reported that CLNX is a classical molecular
chaperone in that it can operate independently of the state
of glycosylation of target proteins (Ihara et al., 1999). The
authors suggest that CLNX recognizes exposed hydropho-
bic pockets in substrate proteins maintaining them in a
folding-competent state. It is then possible that proteins
residing in the ER might benefit from the chaperone activ-
ity of CLNX to allow them to function in the oxidizing/gel
matrix of the ER.
CLNX was first characterized as a phosphoprotein in
the ER (Wada et al., 1991) and more recently, efforts have
been directed to identify the specific residues that support
phosphorylation (Wong et al., 1998). In particular, these
authors described three phosphorylatable residues in the
cytosolic domain of dog CLNX, including the homologous
residue to S562 in rat CLNX. They demonstrate that phos-
phorylation of S562 modulates the interaction of CLNX
with the ribosome. Here, we discovered by site-directed
mutagenesis that the S562 in CLNX supports phosphory-
lation with functional consequences for the control of
Ca21 oscillations. Specifically, unlike the inhibition of
repetitive Ca21 waves observed in oocytes overexpress-
ing CLNX 1 SERCA2b, the frequency of repetitive
waves observed in oocytes overexpressing CLNX-S562A 1
SERCA2b is similar to that of the Ca21 ATPase expressed
Figure 9. Dephosphorylation of CLNX reduces its interaction
with SERCA2b. In vitro translations of synthetic mRNAs were
performed in rabbit reticulocyte lysate supplemented with canine
pancreatic microsomes and L-[35S]methionine. Isolated mi-
crosomes were treated with alkaline phosphatase as described in
Materials and Methods, the samples were subjected to 15% SDS-
PAGE, and detected by fluorography. A positive glycosylation
control of S. cerevisiae a factor was also translated. Paired sam-
ples 6 alkaline phosphatase treatment that were coimmunopre-
cipitated with CLNX were loaded in the following order: nega-
tive control without RNA in the translation (lane 1), S. cerevisiae
a factor (second set of lanes), SERCA2b/TM9-11 (third set of
lanes), and SERCA2b-N1036A/TM9-11 (fourth set of lanes).
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alone. In addition, dominant-negative expression of a pep-
tide encompassing this PKC/PDK phosphorylation site of
CLNX relieved the inhibition of Ca21 oscillations im-
parted by the wild-type chaperone. From these results, we
conclude that S562 in the cytosolic domain of CLNX is a
molecular switch that controls Ca21 oscillations. Our re-
sults suggest that dephosphorylation of S562 removes the
functional interaction of the chaperone with SERCA2b,
resulting in a pump that is no longer inhibited. CLNX has
a second consensus site for phosphorylation by PKC
(S485), although it is not known whether it is functional.
Coexpression of the S485A mutant with SERCA2b de-
creased the number of oocytes that displayed repetitive
waves to 15%, suggesting stronger inhibition of the pump.
Two interpretations are possible for this finding. Either
S485 has opposite effects to S562, or it is nonfunctional.
We resolved this issue by coexpressing the double mutant
CLNX-S562A/S485A with SERCA2b, which also resulted
in inhibition of Ca21 oscillations. This result suggests that
the S485 residue is required for the regulation of the Ca21
oscillations upon dephosphorylation of the distal S562 res-
idue. Interestingly, this proposed mechanism of action is
reminiscent of the relief from inhibition of SERCA2a af-
ter store depletion in cardiac muscle (Bhogal and Colyer,
1998). In this tissue, phosphorylation of phospholamban is
responsible for relief of inhibition of the pump, although a
chaperone interaction is not involved (Jackson and Col-
yer, 1996; MacLennan and Toyofuku, 1996). Thus, CLNX
appears to be the functional equivalent of phospholamban
in nonmuscle cells, where it provides phosphorylation-
Figure 10. Model depicting
the functional consequences
of cytosolic phosphorylation
of CLNX. (1) Under resting
conditions, CLNX is phos-
phorylated on S562 located
in the cytosolic domain of
CLNX as shown. In this state,
we suggest that CLNX is free
to interact with the COOH
terminus of SERCA2b.
CLNX may also interact with
the ribosome. The Ca21 ATP-
ase is inhibited, the Ca21
stores are expected to be full
(dark gray) and in an optimal
condition for protein folding.
(2) Mobilization of the Ca21
stores by IP3 (light gray) re-
sults in a Ca21-dependent de-
phosphorylation of S562 in
CLNX. In the dephosphory-
lated state, inhibition of re-
petitive Ca21 waves by CLNX
is not observed, suggesting a
loss of interaction with the
pump resulting in Ca21 store
refilling. This phosphoryla-
tion switch implies that cyto-
solic Ca21 regulates interac-
tions of CLNX with lumenal
proteins (e.g., SERCA2b), re-
sulting in control of Ca21 up-
take and also modulation of
protein folding in the ER lu-
men. In contrast, a bi-direc-
tional arrow is shown to indi-
cate that the interaction of
CRT with targets is deter-
mined by lumenal condi-
tions. (See Discussion for fur-
ther details).
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dependent regulation of Ca21 uptake by SERCA2b. Fur-
thermore, the mutants S485A and S485A/S562A behaved
like CRT, which lacks cytosolic regulation and is consis-
tent with the observation that a soluble ER lumenal do-
main of CLNX (DTMC), which promotes refolding of ri-
bonuclease B, acts like CRT (Zapun et al., 1997).
The serine residues characterized here conform to a
consensus motif for PKC/PDK phosphorylation (Wong et
al., 1998). From a signaling perspective, activation of the
IP3 pathway would be expected, via PKC, to provide Ca21-
mediated feedback to regulate downstream phosphorylat-
able targets such as CLNX. To test this hypothesis, immu-
noprecipitations of CLNX and CLNX-S562A mutant were
performed from membrane fractions of [32P]ATP-labeled
oocytes in the presence or absence of IP3. These studies re-
vealed that wild-type CLNX was phosphorylated under
resting conditions and dephosphorylated after IP3 injec-
tion. Furthermore, the detected phosphate label is on
S562, since CLNX-S562A has a corresponding decrease in
the amount of phosphate at rest, and more significantly,
there is no further decrease upon stimulation by IP3. We
find that treatment with calf intestinal alkaline phos-
phatase decreases the interaction of CLNX with the
COOH terminus of SERCA2b. This is consistent with the
possibility that dephosphorylation of S562 is transduced to
the ER lumen, causing dissociation of CLNX from
SERCA2b. The phosphatase responsible for the Ca21-
dependent dephosphorylation of CLNX remains to be
identified. A candidate for this role may be the Ca21-
dependent phosphatase, calcineurin (Klee et al., 1998).
Recently, Chevet et al. demonstrated that the equivalent
residue in dog CLNX is phosphorylated by extracellular-
signal regulated kinase 1 (ERK-1), and interestingly, phos-
phorylation by ERK-1 and CKII increased CLNX associa-
tion with ribosomes in pancreatic microsomes (Chevet et
al., 1999). The kinase responsible for phosphorylation of
S562 remains to be identified in the oocyte.
One of the major implications of our study is that CRT
should be viewed as a chaperone that is strictly controlled
by ER lumenal conditions such as Ca21 and interactions
with other proteins (Corbett et al., 1999). In contrast,
CLNX, via phosphorylation of its cytosolic domain, intro-
duces an additional level of complexity to the signaling
that controls protein processing. In Fig. 10, we present a
model describing the Ca21-dependent regulation via cyto-
solic phosphorylation of the interaction of CLNX with
SERCA2b. In this model, we also attempt to incorporate
the recent findings of Chevet et al. (1999) regarding the
phosphorylation-dependent interaction of CLNX with the
ribosome. We suggest that in the resting state (1), CLNX
is phosphorylated on S562 and the Ca21 stores are full.
Furthermore, CLNX is interacting with SERCA2b at the
COOH lumenal terminus, keeping the pump in an inhib-
ited state. CLNX may also be bound to the ribosome
maintaining optimal conditions for folding of newly syn-
thesized proteins as they translocate into the ER. Upon
mobilization of Ca21 from internal stores by IP3 (2), cy-
tosolic Ca21 is increased, activating a phosphatase that
dephosphorylates CLNX, removing its interaction with
SERCA2b, and allowing the pump to refill the Ca21
stores. Dephosphorylation of CLNX also causes its disso-
ciation from the ribosome (Chevet et al., 1999). Since pro-
tein translation is inhibited after store depletion, an inter-
action between CLNX and the ribosome is no longer
required (Reilly et al., 1998). Restoration of ER lumenal
Ca21 has interesting consequences for the maintenance of
ER protein folding. Lumenal Ca21 is required for associa-
tion of the lectin chaperones with misfolded targets, and
more importantly, it is required for the action of the UDP-
Glc glycoprotein glucosyl transferase (Trombetta and Par-
odi, 1992). Furthermore, depletion of Ca21 from inter-
nal stores causes accumulation of misfolded proteins in
the ER (Lodish and Kong, 1990; Lodish et al., 1992;
Choudhury et al., 1997) and upregulation of CRT expres-
sion at the mRNA and protein levels within a few hours
(Llewellyn et al., 1996; Waser et al., 1997). Likewise,
CLNX isoforms in yeast are induced by ER stress (Jan-
natipour and Rokeach, 1995). Our data are consistent with
the idea that dephosphorylation of CLNX is an acute re-
sponse (minutes) to Ca21 store depletion, and removal of
pump inhibition then ensures optimal ER lumenal condi-
tions for protein folding. We suggest that folding events in
the ER lumen are under the control of the IP3-mediated
Ca21 signaling system. Since these chaperones in turn
modulate cytosolic Ca21 by virtue of their putative luminal
interactions with the SERCA2b, this system represents a
novel bi-directional mode of signaling between the ER
and the cytosol.
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